‘Nice bites diabetes’

COVID-19 Medicines Optimisation (26)
- COVID-19 Medicines Optimisation: Information and resources (2)
- COVID-19 Medicines Optimisation: Specialty Guidance (24)
COVID-19 Vaccines (28)
- AstraZeneca Vaccine (8)
  - AstraZeneca Vaccine: Answers to Questions (1)
  - AstraZeneca Vaccine: Handling in PCNs (7)
- General information and guidance (7)
  - All vaccines: Answers to Questions (2)
  - All vaccines: Handling in PCNs (1)
  - All vaccines: Handling in Temporary Vaccination Sites (3)
  - All vaccines: Handling in Trusts and Vaccination Centres (1)
- Moderna Vaccine (7)
  - Moderna Vaccine: Handling in PCNs (7)
- Pfizer-BioNTech Vaccine (8)
  - Pfizer-BioNTech Vaccine: Answers to Questions (1)
  - Pfizer-BioNTech Vaccine: Handling in PCNs (7)
Care Setting (21)
- Care homes (3)
- Care of the elderly (2)
- Community Health Services (4)
- Critical care (1)
- Dentistry (2)
- Health and Justice (6)
- Paediatrics and neonates (3)
- Palliative and End of Life Care (2)
- Primary Care (8)
- Transfer of care (1)
- Trusts (6)
Events (1)
- Past Event (1)
- Webinars (1)
Guidance (69)
- Administering (5)
- Advanced therapy medicinal products (4)
- Best Practice Sharing (2)
- Cold chain management (4)
  - Fridge and freezer manuals (1)
- Disposal (6)
- Dosing (3)
- Implementation (9)
- Legislation (1)
- Monitoring (1)
- Patient Group Directions (26)
- Polypharmacy (1)
- Porphyria (1)
- Preparing (4)
- Regulatory (5)
- Safety in Breastfeeding (1)
- Service advice (2)
- Stability outside the fridge (1)
- Supply (16)
- Switching (2)
Interest areas (22)
- Hospital Pharmacy and Medicines Optimisation Programme (HOPMoP) (3)
- Medicines Safety (17)
- Policy, Commissioning and Managerial (4)
Medicine (19)
- Atorvastatin (1)
- Atovaquone (1)
- Benzyl benzoate (1)
- Betamethasone (1)
- Chloroquine (1)
- Citalopram (1)
- Cyclomethicone + Isopropyl myristate (1)
- Dalteparin (1)
- Dimeticone (2)
- Doxazosin (1)
- Doxycycline (1)
- Enoxaparin (1)
- Fluoxetine (1)
- Fluvastatin (1)
- Fluvoxamine (1)
- Gabapentin (2)
- Gadobutrol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Hydroxychloroquine (1)
- Insulin aspart (1)
- Insulin detemir (1)
- Insulin glargine (2)
- Insulin glulisine (1)
- Insulin human (1)
- Insulin isophane human (1)
- Insulin lispro (1)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Malathion (2)
- Metformin (1)
- Methylphenidate (1)
- Paroxetine (1)
- Pravastatin (1)
- Pregabalin (2)
- Proguanil (1)
- Proguanil + Atovaquone (1)
- Retinol + Vitamin D (1)
- Rosuvastatin (1)
- Sertraline (1)
- Simvastatin (1)
- TICE strain Bacillus of Calmette-Guerin (1)
- Tinzaparin (1)
- Ubidecarenone (1)
- Venlafaxine (1)
- Warfarin (1)
Networks (7)
- Antimicrobial resistance networks (6)
- Pan-UK ATMP Pharmacy Working Group (1)
Planning (6)
- New Medicines (3)
  - NHS England commissioned new medicines (2)
- Patient Group Direction Planning (3)
Publications (35)
- RMOC recommendations and resources (2)
- Research and audits (5)
- Standard Operating Procedures (21)
- Summary advice (3)
- Templates (4)
Specialty (40)
- Allergy and immunology (3)
- Anaesthesia and pain (1)
- Cancers (2)
- Cardiovascular system disorders (3)
- Diabetes (2)
- Endocrine system disorders (1)
- Eyes and vision (1)
- Gastrointestinal disorders (2)
- Haematological disorders (3)
- Infection and infectious diseases (1)
- Learning disabilities (1)
- Mental health and illness (7)
- Musculo-skeletal disorders (2)
- Nutritional and metabolic disorders (3)
- Obstetrics and gynaecology (2)
- Public Health (1)
- Renal and urologic disorders (3)
- Reproductive health (1)
- Respiratory disorders (1)
- Skin disorders (2)
- Stroke (1)
- Surgery (2)
- Travel Medicine (1)
Training (2)
- Training materials (2)

Summary of COVID-19 medicines guidance: Diabetes

11 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…

Safety in Lactation: Insulins

23 September 2020Exogenous insulin is excreted into breast milk, including that from insulin analogues. Insulin in breast milk is thought to be necessary for intestinal maturation of…

Type 2 Diabetes Frailty Reviews in Older People

28 August 2019The number of older people with type 2 diabetes and frailty is growing. These patients are at increased risk of adverse effects from blood glucose…

RMOC Best Value Biologic – Insulin Glargine Toolkit: Consultation running until 24/12/2020

26 November 2020A draft toolkit has been produced on Best value biologic – insulin glargine, on behalf of the RMOC system. Insulin glargine is the first medicine managed…

Terms and Conditions

References in these terms to “NHS SPS”, “SPS”, “we” and “our” are references to the National Health Service England Specialist Pharmacy Service. These terms apply…

Sheffield CCG AMR network

The main remits of the Sheffield Antimicrobial Stewardship Group are: To optimise antimicrobial prescribing practice in primary and secondary care also including out of hours…

SPS Horizon Scanning Service

20 January 2021SPS produces a range of information to support managed entry of new drugs into the NHS, to assist organisations in developing medicines management policies and…

Metformin for hirsutism and acne in polycystic ovary syndrome (PCOS)

22 August 2021Metformin may be used to treat some of the symptoms of PCOS but its effectiveness at treating hirsutism and acne is less clear.

New Product Evaluations

11 October 2021A list of new product evaluations that are freely available to NHS staff via the internet. The list is updated monthly, and newly published reviews…

Use of Patient Group Directions by registered healthcare professionals undertaking training or competency assessment

8 September 2020This Q&A outlines the advice on the use of PGDs by registered healthcare professionals who are undertaking training and/or competency assessment.

SPS - Specialist Pharmacy Service

NHS